News & Events
An error has occured
to go to the homepage.
10 February 2014. EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan™ DNA-enrichment technology at Tri-Con 2014.
EKF Diagnostics, announces that EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan™ DNA-enrichment technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.
20 January 2014. PointMan™ successfully enriches low-level mutations in DNA extracted from blood.
EKF Diagnostics Holdings plc,announces a major breakthrough for its Pointman technology for potential use in future cancer testing and treatment.
8 January 2014. EKF Diagnostics’ Quo-Lab HbA1c Analyzer Secures IFCC Certification.
Point-of-care analyzer meets all standards set by independent certifying bodies.
4 March 2014. Transfer of production.
EKF Diagnostics announces that the Company proposes to transfer all production of Quo-Test and Quo-Lab instruments and reagents cartridges.
26 February 2014. Final results for the year ended 31 December 2013.
EKF Diagnostics Holdings plc, announces its audited final results for the year ended 31 December 2013, a year of strong organic growth and improved earnings.
17 February 2014. Notice of results.
EKF Diagnostics Holdings plc, the point-of-care diagnostics business, will announce results for the financial year ended 31 December 2013, on Wednesday 26 February 2014.
General Terms of Sale and Delivery
Website designed by atticusdigital